OCT-guided laser phototherapeutic keratectomy
PreclinicalSmall molecule
OCT-guided laser phototherapeutic keratectomy is one of 3 small molecule programs targeting Optical Coherence Tomography. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in Optical Coherence Tomography
#DrugCompanyPhaseTrials
1PCSK9 Inhibitor
YYun Dai Chen
Phase 3
Unfractionated Heparin
GSKPreclinical
OCT-guided laser phototherapeutic keratectomy
OOregon Health and Science University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details